A lanperisone hydrochloride compression-molded formulation comprising the first granules containing lanperisone hydrochloride and the second granules containing substantially no lanperisone hydrochloride but at least one pharmaceutical additive(s) selected from the group consisting of sugars, crystalline celluloses and cellulose derivatives is an excellent formulation which has a high storage stability because the decomposition of lanperisone hydrochloride is suppressed.
盐酸兰哌立松压缩模塑制剂由含有
盐酸兰哌立松的第一种颗粒和基本上不含
盐酸兰哌立松但含有至少一种从糖、结晶
纤维素和
纤维素衍
生物组成的组中选出的药物添加剂的第二种颗粒组成,是一种出色的制剂,由于抑制了
盐酸兰哌立松的分解,因此具有很高的贮存稳定性。